Assessment of safety in pediatric psychopharmacology.
Greenhill
Laurence L
LL
New York State Psychiatric Institute, New York, NY 10032, USA. LarryLGreenhill@cs.com
D000293:Adolescent; D001008:Anxiety Disorders / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D016666:Fluvoxamine / Q000627:therapeutic use; D006801:Humans; D017093:Liver Failure / Q000209:etiology; D008297:Male; D009325:Nausea / Q000209:etiology; D011600:Psychopharmacology; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012107:Research Design; D012449:Safety; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
D016666:Fluvoxamine; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors